Since 1960, various compounds have been shown to inhibit some of the actions of bradykinin (Mariani, 1961; Collier, 1961; Garcia-Leme & Rocha e Silva, 1965) and angiotensin (Schaper, Jageneau, Xhonneux, Van Nueten & Janssen, 1963; Godfraind, Kaba & Polster, 1966; Gascon & Walaszek, 1966) . The first compound which has been found to antagonize the actions of eledoisin is the flavonoid derivative morin (Fig. 1) . On the guinea-pig ileum this substance reversibly but noncompetitively inhibits the actions of eledoisin in concentrations which do not effect the responses to angiotensin and bradykinin and which slightly potentiate the actions of acetylcholine (Gascon, 1968a) . Morin also inhibits the effects of eledoisin on isolated rabbit atria (Gascon, 1968b) but does not significantly reduce the hypotensive action of eledoisin in the rat. In order to elucidate this lack of activity in vivo, we studied the influence of rat plasma and of various cations on the anti-eledoisin activity of morin in vitro, using the isolated guinea-pig ileum.
Methods
Guinea-pig ileum Strips 2-3 cm long suspended at 300 C in a 10 ml. bath of Tyrode solution gassed with a mixture of 95% oxygen and 5% carbon dioxide. Eledoisin was added at * Scholar of the Medical Council of Canada. constant intervals of 5 min and left in contact with the smooth muscle for 60 sec. The contractions induced by the agonist were recorded on a smoked drum with a frontal writing lever. Responses were first obtained to a series of four doses of eledoisin, each sequence being repeated two or three times. Morin was added to the perfusion medium in a final concentration of 2 or 4 ug/ml. and kept in continuous contact with the preparation. The influence of rat plasma and of various cations was evaluated at a concentration of 4 ml./1. and 6 x 10-6M, respectively.
Preparation of rat plasma
Fresh plasma. Fresh plasma was obtained by centrifugation of heparinized blood withdrawn from the abdominal aorta of the ether-anaesthetized animal.
Deproteinized plasma. To obtain deproteinized plasma, perchloric acid 10% was added to the fresh rat plasma until no more precipitation occurred; the mixture was then kept at 50 C overnight before being centrifuged and neutralized.
Deionized plasma. Deproteinized plasma was allowed to run through a column of Amberlite MB1, an intimate mixture of Amberlite IR-120 and Amberlite Blood pressure experiments Male Sprague-Dawley rats weighing 150-200 g were pretreated with N-acetyl-(±)-penicillamine (4 mg/day per rat, i.p.) for periods ranging from 5 to 15 days.
The rats were treated with guanethidine 10 mg/kg (Miele & DeNatale, 1965) 
Statistical analysis
The statistical analyses used were: determination of the correlation coefficient, regression analysis and the Student t test, which was applied to the slope of the regression curves.
Results
Guinea-pig ileum In the first series of experiments, we studied the influence of fresh rat plasma on the anti-eledoisin activity of morin. The results (Fig. 2) indicate that morin (2 and 4 ,ug/ml.) produces a marked reduction in the musculotropic activity of eledoisin. Furthermore, it can be observed that when fresh rat plasma is added to the perfusion mixture before the addition of morin (2 and 4 ,g/ml.), the latter compound loses its inhibitory effect completely. Similar results were obtained when deproteinized plasma was used (Fig. 3 ). When deionized plasma was added to the Tyrode solution, however, morin was still able to antagonize the musculotropic activity of eledoisin (Fig. 4) .
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Log dose FIG. 2. Influence of fresh rat plasma on the anti-eledoisin activity of morin on the isolated guinea-pig ileum. Abscissa, log dose eledoisin; ordinate, E/EAmax where E is the effect produced by a given concentration. of eledoisin and EA.m is the maximum effect produced by eledoisin. O -0, Normal; *--morin 2 jgg/ml.; A--/\, morin 4 jug/ml.; ---0, morin 2 ,ug/ml.+fresh plasma (4 ml./1.); *---, morin 4 ggg/ml.+fresh plasma (4 ml./l.). guinea-pig ileum. Abscissa, log dose eledoisin; ordinate, E/EAmax where E is the effect produced by a given concentration of eledoisin and EAmax is the maximum effect produced by eledoisin. O O, Normal; C}----, morin 2 ,gg/ml.+deionized plasma (4 ml./1.); i *--fl, morin 4 ,ug/ml.+deionized plasma (4 ml./l.); *--, morin 4 ,g/ml.+deionized plasma (4 ml./1.)+cupric acetate 6 x 10-6M.
We next studied the ability of various cations to restore the inhibitory effect of deionized plasma, using the acetate salts of the following cations: copper, cadmium, cobalt, zinc, strontium, nickel, aluminium and lead. Among these salts only cupric acetate could restore the inhibitory action of the deionized plasma (Fig. 4) .
In another series of experiments, we studied the influence of cupric acetate and also the influence of a mixture of cupric acetate and N-acetyl-(±)-penicillamine (4 ,ug/ml.) on the inhibition induced by morin. Figure 5 shows the responses of a piece of guinea-pig ileum to eledoisin, the inhibitory effects of morin, the reversal of the effects of morin by cupric acetate and the failure to reverse the effects of morin when cupric acetate is added together with N-acetyl-(±)-penicillamine.
If be able to abolish this inactivation. The results in Fig. 6 are in agreement with this hypothesis: when morin was mixed with fresh rat plasma, the musculotropic activity of eledoisin was preserved. When the rat plasma was mixed with N-acetyl-( ±)-penicillamine (4 g g/ml.) 30 min before its addition to the perfusion fluid, however, the anti-eledoisin activity of morin could still be elicited. In the last series of experiments, we studied the influence of plasma obtained from rats pretreated with N-acetyl-(+)-penicillamine (4 mg/day per rat, i.p.) for periods of 5, 10 and 15 days on the anti-eledoisin activity of morin. The results in Fig. 7 indicate that after 5 days of pretreatment, there was still a reduction in the inhibitory effect of morin. There was no significant difference between the normal regression curve and the curve for morin plasma (5 days) or between the curves obtained with morin and morin + plasma, but the plasma no longer significantly modified the inhihitory power of morin after 10 days (Fig. 8) or after 15 days of pretreatment (Fig. 9) . Rat blood pressure The results observed on rat blood pressure were similar to those reported previously (Gascon, 1968a) ; that is, the hypotensive effect of eledoisin could not be modified by morin. Furthermore, in a series of ten experiments we also studied the influence of the flavonol derivative in rats pretreated 15 days with N-acetyl-(±)-penicillamine. Even in the pretreated animals, morin failed to antagonize the action of eledoisin.
Discussion
The results obtained here confirm our previous findings (Gascon, 1968a ) that eledoisin antagonizes the musculotropic activity of eledoisin on the isolated guineapig ileum. In addition, we observed that, when fresh rat plasma or deproteinized rat plasma is added to the Tyrode solution before the addition of morin, the latter completely loses its anti-eledoisin activity, indicating that both types of plasma have the ability to inactivate the flavonoid derivative and that the plasma proteins do not seem to play a part in this inactivation. On the basis of its structure (Fig. 1) , it could be thought that morin would be a potent chelator, a property that has been reported for most of the flavonoids (Clark & Geissman, 1949) and also that part of its inactivation may be the result of the formation of a complex with some plasma cations. The fact that the deionized plasma does not abolish the inhibitory effect of morin supports the idea that formation of a complex between morin and some plasma cation occurs. In this connection, addition of cupric acetate to the deionized plasma restored the ability of the deionized plasma to inactivate morin, but all the other cations studied were inactive even at concentrations much higher than their respective content in rat plasma.
From these results, we can conclude that the inactivation of morin by the rat plasma was due to the formation of a complex with the plasma copper. This conclusion is supported by the fact that the effect of fresh rat plasma as well as that of cupric acetate is abolished by (-)-penicillamine and N-acetyl-(±)-penicillamine, two copper chelators (Goodman & Gilman, 1965 of this hypothesis is that the plasma of animals treated for 10 to 15 days with N-acetyl-(±)-penicillamine did not reduce the anti-eledoisin activity of morin.
The interaction between morin and the plasma copper does not, however, explain the lack of effect of morin on the rat blood pressure, because the eledoisin inhibitor is still inactive in animals previously treated with N-acetyl-(±)-penicillamine for 15 days. The absence of anti-eledoisin activity of morin on the blood pressure may be the result of an interaction between the flavonoid and the copper cations in other tissues. Another possibility is the rapid biotransformation of morin by some enzymatic system. I wish to thank Mrs. C. Denniel and Miss G. Bouchard for technical assistance. This study was supported in part by the Medical Research Council of Canada (MA-2431) and by the Quebec Heart Foundation. E E Dose (ng) FIG. 9. Responses of a piece of guinea-pig ileum to eledoisin; influence of plasma from animals pretreated with N-acetyl-(±)-penicillamine (4 mg/rat per day for 15 days) on the inhibiting effects of morin. Abscissa, log dose eledoisin; ordinate, size of record of contraction (mm). O-0, Normal; * *, morin 4 gsg/ml.+plasma (4 ml./l.); -, morin 4 ,ug/ml. 
